Nidda Healthcare GmbH

  • Land: Deutschland

Nachricht vom 11.10.2018 | 15:12

Nidda Healthcare GmbH: Public delisting tender offer for the remaining STADA shares launched

DGAP-News: Nidda Healthcare GmbH / Key word(s): Offer/Delisting

11.10.2018 / 15:12
The issuer is solely responsible for the content of this announcement.


  • Offer document published today following approval by BaFin
  • Four-week acceptance period for the offer ends on Thursday 8 November 2018
  • Offer price determined by BaFin equal to the six-months weighted average stock exchange price of EUR 81.73 per STADA share

Frankfurt / Munich, 11 October 2018 - Nidda Healthcare GmbH ("Nidda Healthcare"), a company controlled by funds advised by Bain Capital Private Equity (Europe), LLP ("Bain Capital") and Cinven Partners LLP ("Cinven"), today published the offer document for the public delisting tender offer ("Offer") for all shares of STADA Arzneimittel AG ("STADA" or the "Company") following approval of the publication of the offer document by the German Federal Financial Supervisory Authority ("BaFin").

The four-week acceptance period has started today and will end at midnight (CET) on Thursday 8 November 2018. The Offer is unconditional and there will be no additional acceptance period. In order to tender their shares, STADA shareholders must issue a written or electronic declaration to their respective custodian bank within the next four weeks. Further information can be found in the offer document.

Nidda Healthcare offers the shareholders of STADA a cash consideration of EUR 81.73 per STADA share equal to the weighted average domestic stock exchange price of STADA shares during the last six months prior to its announcement of the decision to make a public delisting tender offer as determined by BaFin. The cash consideration represents a premium of approx. 23.5 percent on the offer price of EUR 66.25 per STADA share during the successful takeover offer in 2017, and a premium of 10 percent on the cash compensation of EUR 74.40 offered to minority shareholders in the context of the domination and profit and loss transfer agreement.

The German version of the offer document and a non-binding English translation are now available for distribution free of charge at BNP Paribas Securities Services S.C.A., Zweigniederlassung Frankfurt, Europa-Allee 12, 60327 Frankfurt am Main, Germany (requests to be made by providing a complete address by fax on +49 69 1520 5277 or via e-mail to frankfurt.gct.operations@bnpparibas.com). Furthermore, the offer document is available on the internet at www.niddahealthcare-offer.com.

 

Media contacts:

For Bain Capital
Hazel Stevenson                                           
T   +44 (0) 20 375 74 989                                 
M  +44 (0) 798 600 97 20                          
E   hazel.stevenson@camarco.co.uk        
 
Ed Gascoigne-Pees
T   +44 (0) 20 375 74 984
M +44 (0) 788 400 19 49
E   ed.gascoigne-pees@camarco.co.uk
  
For Cinven
Vanessa Maydon                                          
T   +44 (0) 20 766 13325                            
M +44 (0) 7802 961 902                             
E   vanessa.maydon@cinven.com
 
Lutz Golsch
T   +49 69 92037 110                                  
M +49 173 651 7710
E   lutz.golsch@fticonsulting.com


About Bain Capital Private Equity:

Bain Capital Private Equity has partnered closely with management teams to provide the strategic resources that build great companies and help them thrive since its founding in 1984. Bain Capital Private Equity's global team of approximately 240 investment professionals creates value for its portfolio companies through its global platform and depth of expertise in key vertical industries including healthcare, consumer, financial and business services, industrials, and technology. Bain Capital's broader platform has offices in Boston, Chicago, New York, Palo Alto, San Francisco, Dublin, London, Luxembourg, Madrid, Munich, Melbourne, Mumbai, Hong Kong, Shanghai, Guangzhou, Seoul, Sydney and Tokyo and has made investments in more than 320 companies to date. In addition to private equity, Bain Capital invests across asset classes including credit, public equity, venture capital and real estate managing approximately USD 105 billion in total and leveraging the firm's shared platform to capture opportunities in strategic areas of focus.

For more information, visit www.baincapitalprivateequity.com

 

About Cinven:

Cinven is a leading international private equity firm focused on building world-class European and global companies. Its funds invest in six key sectors: Healthcare, Business Services, Consumer, Financial Services, Industrials, and Technology, Media and Telecommunications (TMT). Cinven has offices in key locations including: Frankfurt, London, Paris, Milan, Madrid, Hong Kong, and New York. Since 1988, Cinven funds have invested in 120 companies worth around EUR90 billion. Today Cinven has more than EUR15 billion in assets under management. Cinven takes a responsible approach towards its portfolio companies, their employees, suppliers, local communities, the environment and society.

For more information, please visit www.cinven.com


Important Notice

This announcement is neither an offer to purchase nor a solicitation of an offer to sell shares of STADA. The definite terms of the Offer, as well as further provisions concerning the Offer, are published in the offer document. Investors and holders of STADA shares are strongly advised to read the offer document and all other relevant documents regarding the Offer, since they contain important information.

The Offer is issued exclusively under the laws of the Federal Republic of Germany and certain applicable provisions of U.S. securities law. Any contract that is concluded on the basis of the Offer will be exclusively governed by the laws of the Federal Republic of Germany and is to be interpreted in accordance with such laws.



11.10.2018 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


show this

Interview im Fokus

„Bitcoin kurz vor dem Durchbruch“

Die Northern Bitcoin AG verzeichnet nicht nur ein rasantes Wachstum als führender Bitcoin-Miner, die Frankfurter betreiben auch einen klimaneutralen Bitcoin-Mining-Pool. Die strategische Zusammenarbeit mit der Rawpool-Gruppe katapultiert Northern Bitcoin „in eine völlig neue Dimension“, ist CEO Mathis Schultz überzeugt: „Der Bitcoin wird die Welt dramatisch verändern. Wir sehen uns exzellent aufgestellt, um in den kommenden Jahren als Pionier das führende europäische Unternehmen im Bereich Bitcoin-Blockchain aufzubauen.“

GBC-Fokusbox

BIG Blockchain Intelligence Group: Coverage Initiated mit Kaufen-Rating

BIG Blockchain Intelligence Group Inc. bietet Software-Lösungen an, die eine Echtzeitüberprüfung von blockchainbasierten Transaktionen mit Hilfe von Such- und Analysefunktionen ermöglicht. Zur Kernkompetenz gehört eine Software, die zur Generierung von Daten aus Blockchain-Transaktionen verwendet wird. Aktuell konzentriert sich BIG auf Transaktionen von Kryptowährungen und bedient seine Kunden wie Regierungen, Strafverfolgungsbehörden, Banken und Finanzdienstleistern oder E-Commerce-Anbieter mit entsprechender Sicherheitstechnologie. Bei einem Kursziel von 1,03 CAD (0,69 €) lautet das Rating KAUFEN.

News im Fokus

Fresenius SE & Co. KGaA: Fresenius bestätigt und konkretisiert Konzernausblick für das Geschäftsjahr 2018

16. Oktober 2018, 23:09

Aktuelle Research-Studie

CO.DON AG

Original-Research: CO.DON AG (von Sphene Capital GmbH): Buy

17. Oktober 2018